1. Home
  2. NEPH vs RAND Comparison

NEPH vs RAND Comparison

Compare NEPH & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nephros Inc.

NEPH

Nephros Inc.

SELL

Current Price

$2.64

Market Cap

35.3M

Sector

Health Care

ML Signal

SELL

Logo Rand Capital Corporation

RAND

Rand Capital Corporation

N/A

Current Price

$8.53

Market Cap

30.6M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NEPH
RAND
Founded
1997
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
35.3M
30.6M
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
NEPH
RAND
Price
$2.64
$8.53
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $6.08
N/A
AVG Volume (30 Days)
★ 74.5K
1.0K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
★ 13.63%
EPS Growth
★ 1000.00
N/A
EPS
0.17
★ 0.65
Revenue
★ $18,789,000.00
N/A
Revenue This Year
$17.81
N/A
Revenue Next Year
$15.90
N/A
P/E Ratio
$16.65
★ $13.09
Revenue Growth
★ 32.67
N/A
52 Week Low
$2.66
$8.51
52 Week High
$6.42
$17.49

Technical Indicators

Market Signals
Indicator
NEPH
RAND
Relative Strength Index (RSI) 35.31 35.31
Support Level $2.76 N/A
Resistance Level $3.78 $10.09
Average True Range (ATR) 0.21 0.23
MACD -0.01 -0.09
Stochastic Oscillator 5.66 12.84

Price Performance

Historical Comparison
NEPH
RAND

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

About RAND Rand Capital Corporation

Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. Its investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.

Share on Social Networks: